Titlebook: Hepatocellular Carcinoma; Giuseppe Maria Ettorre Book‘‘‘‘‘‘‘‘ 2023 The Editor(s) (if applicable) and The Author(s) 2023 Hepatic resection.

豎琴

muscle-fibers

Epidemiological Aspects of Hepatocellular Carcinoman (69.8% of all HCC are in men) and the ninth in women. HCC incidence rates vary greatly according to geographic areas: 72.5% of all cases are registered in Asia, with 11.6 new cases per year every 100,000 inhabitants. In the United States and Europe, HCC is less common, with 5.2 new yearly cases pe

明確

Molecular and Genetic Mechanisms of Hepatocellular Carcinomag attention to preventive medicine and the advancement of imaging techniques, HCC is often diagnosed in an advanced stage and represents a leading cause of death among malignancies. Currently available treatment options show important limits, such as high recurrence of HCC, small number of properly

PARA

CHIP

標準

hypertension

follicular-unit

眉毛

Percutaneous and Laparoscopic-Assisted Ablation of Hepatocellular Carcinomas made possible by improvements both in ablation techniques and in image-guidance tools. Percutaneous ethanol injection (PEI) has been largely replaced by hyperthermal ablative therapies—radiofrequency ablation (RFA) and microwave ablation (MWA)—that demonstrated to be equally safe and more effectiv

dearth

Endovascular Treatments of Hepatocellular Carcinomaial treatment including chemoembolization (TACE) and radioembolization (TARE) has been growing rapidly. TACE consists in the delivery of embolic material and anticancer drugs to the liver tumors. The procedure presents several technical variations based on the embolic material and drugs administered